Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2003
03/27/2003WO2003025138A2 Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
03/27/2003WO2003025131A2 Protein modification and maintenance molecules
03/27/2003WO2003025129A2 Neurotransmission-associated proteins
03/27/2003WO2003025128A2 Quinone reductase 2 and aldehyde dehydrogenase as therapeutic targets
03/27/2003WO2003025117A2 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor
03/27/2003WO2003025018A2 Dimeric and multimeric antigen binding structure
03/27/2003WO2003025017A1 Cytokine receptor
03/27/2003WO2003025013A1 Asparagine hydroxylation of the cad domain of a hif protein
03/27/2003WO2003025012A2 Therapeutic vaccine peptide complex for preventing and treating disorders in mammals
03/27/2003WO2003024994A1 Detection and treatment of cancers of the lung
03/27/2003WO2003024993A2 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
03/27/2003WO2003024954A1 Novel terthiophene-3-carboxylic acid compound and fabricating method thereof, functionalized conductive terthiophene polymer with the compound as a monomer, process for dna hybridizatioon detection using the polymer, and fabricating method of probe dna
03/27/2003WO2003024469A1 New antitumor agent
03/27/2003WO2003024442A2 Valproic acid and derivatives for the combinatorial therapeutic treatment of human cancers and for the treatment of tumor metastasis and minimal residual disease
03/27/2003WO2003024411A2 Clinical trial method for caries treatment agents
03/27/2003WO2003024405A2 Methods and compositions for inhibiting the proliferation of prostate cancer cells
03/27/2003WO2003024392A2 Compositions and methods for the diagnosis and treatment of tumor
03/27/2003WO2003024388A2 Methods and compositions for treating and preventing skin disorders using binding agents specific for psma
03/27/2003WO2003024386A2 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
03/27/2003WO2003024308A2 Methods of assaying connective tissue growth factor
03/27/2003WO2003024306A2 Early diagnosis of stroke
03/27/2003WO2003024304A2 Detection and treatment of cancers of the liver
03/27/2003WO2003024302A2 Detection and treatment of cancers of breast
03/27/2003WO2003012434A9 Variable depth automated dynamic water profiler
03/27/2003WO2003005033A8 Carcinoma-related peptides
03/27/2003WO2003000732A3 Fragments of the retinoic acid-related orphan receptor (ror) comprising the lig and binding domain (lbd), crystal structure of the lbd of ror-beta and their applications
03/27/2003WO2003000119A3 Characterization of fluids using ultrasound
03/27/2003WO2003000026A3 Integrated automatic blood collection and processing unit
03/27/2003WO2003000012A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
03/27/2003WO2002099380A3 Optical red and white blood cell differentiation
03/27/2003WO2002098889A3 MAP3Ks AS MODIFIER OF THE p53 PATHWAY AND METHODS OF USE
03/27/2003WO2002098356A3 Ppp2cs as modifiers of the p53 pathway and methods of use
03/27/2003WO2002092837A9 Nucleic and molecule associated with prostate cancer and melanoma immunodetection and immunotherapy
03/27/2003WO2002090941A3 Viscosity sensor
03/27/2003WO2002079739A9 Concentration detection system
03/27/2003WO2002077614A3 Apparatus for the automation of chemical reaction kinetics studies
03/27/2003WO2002077168A3 Mch1r deficient mice
03/27/2003WO2002068927A3 Using viruses to detect or purify proteins
03/27/2003WO2002068633A3 Compositions and methods relating to lung specific genes and proteins
03/27/2003WO2002066596A3 Device and method for analyzing ion channels in membranes
03/27/2003WO2002061144A3 Brain tumor diagnosis and outcome prediction
03/27/2003WO2002059620A3 Detection and quantification of cripto-1
03/27/2003WO2002058534A8 Compositions and methods for the therapy and diagnosis of colon cancer
03/27/2003WO2002057796A3 Compounds for treating pathologies associated with molecular crystallization
03/27/2003WO2002057791A3 Diagnostic and therapeutic compositions and methods related to grp 38
03/27/2003WO2002055992A3 Intrinsically fluorescent, self-multimerizing mhc fusion proteins and complexes thereof
03/27/2003WO2002053761A3 Recombinant protective protein from $i(streptococcus pneumoniae)
03/27/2003WO2002053717A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/27/2003WO2002048358A3 Regulation of human chemokine-like receptor
03/27/2003WO2002046762A3 Optical disc assemblies for performing assays
03/27/2003WO2002046414A3 Human g-protein coupled receptor expressed highly in kidney
03/27/2003WO2002044732A3 Method for diagnosing allergic diseases
03/27/2003WO2002044377A3 Obp1:a protein selectively expressed in osteoblasts
03/27/2003WO2002044374A3 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof
03/27/2003WO2002044326A3 Methods for detection of a target nucleic acid by capture
03/27/2003WO2002044195A3 Method for base sequencing and biologically active nucleic acids
03/27/2003WO2002036821A3 Method for the amplification and optional characterisation of nucleic acids
03/27/2003WO2002033415A3 Pattern recognition method for diagnosis of systemic autoimmune diseases
03/27/2003WO2002033086A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/27/2003WO2002033084A3 Identification of the dombrock blood group glycoprotein as a polymorphic member of the adp-ribosyltransferase gene family
03/27/2003WO2002029060A3 Hematopoietin receptors hpr1 and hpr2
03/27/2003WO2002026951A3 Oxidoreductases
03/27/2003WO2002026934A9 System and process for validating, aligning and reordering genetic sequence maps using ordered restriction map
03/27/2003WO2002024892A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding them, and uses thereof
03/27/2003WO2002022684A3 Transporters and ion channels
03/27/2003WO2002022076A3 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
03/27/2003WO2002018954A9 Inhibition of cmv infection and dissemination
03/27/2003WO2002016585A3 Imidazoline receptor homologs
03/27/2003WO2002016419A9 Progression suppressed gene 13 (psgen 13) and uses thereof
03/27/2003WO2002014830A3 Method of identification and quantification of biological molecules and apparatus therefore
03/27/2003WO2002012902A3 Split-ubiquitin based reporter systems and methods of their use
03/27/2003WO2002012340A3 Transporters and ion channels
03/27/2003WO2002009750A3 Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene
03/27/2003WO2002005857A3 Phosphatonin-related gene and methods of use thereof
03/27/2003WO2002000692A3 Pd-l2 molecules: pd-1 ligands and uses therefor
03/27/2003WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents
03/27/2003WO2001088538A3 Compositions and methods for epitope mapping
03/27/2003WO2001079557A3 Gtp-binding protein useful in treatment and detection of cancer
03/27/2003WO2001062954A3 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents
03/27/2003US20030060994 Method for rapid calibration of beverage dispensing machine
03/27/2003US20030060984 Automobile oil deterioration diagnosing apparatus
03/27/2003US20030060983 Proteomic analysis
03/27/2003US20030060726 Breath-based diagnostic device including a array of multiple sensors
03/27/2003US20030060647 Differential labelling method
03/27/2003US20030060620 Methods and apparatus for the recovery of nucleic acids
03/27/2003US20030060619 Antibody for use in the disgnosis and treatment of kidney, urogenital, and sex disorders
03/27/2003US20030060616 Type II IL-1 receptors
03/27/2003US20030060605 Polypeptide for use in the treatment of tumors, autoimmune, inflammatory and viral diseases
03/27/2003US20030060602 Polypeptide for use in human therapeutics and diagnostics
03/27/2003US20030060601 Polypeptide for use in human therapeutics and diagnostics
03/27/2003US20030060600 Polypeptide for use in human therapeutics and diagnostics
03/27/2003US20030060512 Modulation of inflammation related to columnar epithelia
03/27/2003US20030060493 Kit comprising a pharmaceutical composition containing repinotan or a physiologically acceptable salt of repinotan, and a means for the determination of the concentration of repinotan or its metabolites in body
03/27/2003US20030060457 Cellular proteins as targets for the treatment of pathogens resistant to drugs that target pathogen-encoded proteins
03/27/2003US20030060431 Base analogues
03/27/2003US20030060407 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030060406 Nucleotide sequence that encodes an amino acid sequence by culturing the host cell for expression of polypeptide; agonist or antagonist
03/27/2003US20030060401 Genetic engineered drug
03/27/2003US20030059956 Detecting concentration of transforming growth factor in urine; obtain urine sample, acidify, neutralize, centrifuge, filter to remove salts, concentrate neutralized specimens
03/27/2003US20030059955 Affinity tag modified particles
1 ... 2624 2625 2626 2627 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 ... 3937